These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35984439)

  • 21. Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: a 12 years observational study.
    Viswanathan V; Tilak P; Kumpatla S
    Indian J Med Res; 2012 Jul; 136(1):46-53. PubMed ID: 22885263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of guideline adherence and parameter control on the clinical outcomes in patients with diabetic nephropathy.
    Lu J; Zhao W; Chen T; Xu Z; Sun X; Xie H; An Y; Zeng C; Hu G; Xie G; Liu Z
    BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32675172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus.
    Wang N; Xu Z; Han P; Li T
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27537245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.
    Patente TA; Mohammedi K; Bellili-Muñoz N; Driss F; Sanchez M; Fumeron F; Roussel R; Hadjadj S; Corrêa-Giannella ML; Marre M; Velho G
    Free Radic Biol Med; 2015 Sep; 86():16-24. PubMed ID: 25862415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in the prevalence of diabetic nephropathy in type 1 and type 2 diabetes.
    Harvey JN
    Curr Opin Nephrol Hypertens; 2003 May; 12(3):317-22. PubMed ID: 12698072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan.
    Yokoyama H; Okudaira M; Otani T; Sato A; Miura J; Takaike H; Yamada H; Muto K; Uchigata Y; Ohashi Y; Iwamoto Y
    Kidney Int; 2000 Jul; 58(1):302-11. PubMed ID: 10886575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.
    Huang JX; Liao YF; Li YM
    Curr Med Sci; 2019 Oct; 39(5):754-758. PubMed ID: 31612393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort study.
    Avdic T; Eliasson B; Rawshani A; Boren J; Gerstein HC; Nordanstig J; Rihawi M; Beckman JA; McGuire DK; Omerovic E; Sattar N; Bhatt DL; Rawshani A
    Lancet Reg Health Eur; 2024 Apr; 39():100852. PubMed ID: 38803631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations Between High-Altitude Residence and End-Stage Kidney Disease in Chinese Patients with Type 2 Diabetes.
    Zhao L; Wang X; Wang T; Fan W; Ren H; Zhang R; Zou Y; Xu H; Zhang J; Wu Y; Liu F
    High Alt Med Biol; 2020 Dec; 21(4):396-405. PubMed ID: 33185478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study.
    Möllsten A; Svensson M; Waernbaum I; Berhan Y; Schön S; Nyström L; Arnqvist HJ; Dahlquist G; ; ;
    Diabetes; 2010 Jul; 59(7):1803-8. PubMed ID: 20424230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose.
    Lin CC; Chen CC; Chen FN; Li CI; Liu CS; Lin WY; Yang SY; Lee CC; Li TC
    Am J Med; 2013 Nov; 126(11):1017.e1-10. PubMed ID: 23993260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex Differences in Biopsy-Confirmed Diabetic Kidney Disease.
    Wang Y; Zhang J; Zhang J; Wu Y; Zhang R; Ren H; Cooper ME; Liu F
    Front Endocrinol (Lausanne); 2021; 12():670674. PubMed ID: 34393995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of poorly controlled HbA1c with increased risk of progression to end-stage kidney disease and all-cause mortality in patients with diabetes and chronic kidney disease.
    Chen SJ; Chiang HY; Chen PS; Chang SN; Chen SH; Wu MY; Yeh HC; Ting IW; Tsai HC; Chen PC; Kuo CC
    PLoS One; 2022; 17(9):e0274605. PubMed ID: 36155491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease.
    Villar E; Polkinghorne KR; Chang SH; Chadban SJ; McDonald SP
    Diabetologia; 2009 Dec; 52(12):2536-41. PubMed ID: 19756481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modifiable factors related to 7-year renal outcomes in subjects with type 2 diabetes and chronic kidney disease stage 3.
    Huang CH; Chen CP; Huang YY; Hsu BRS
    J Postgrad Med; 2020; 66(4):187-193. PubMed ID: 33037171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
    Romero P; Salvat M; Fernández J; Baget M; Martinez I
    J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.
    Ceriello A; De Cosmo S; Rossi MC; Lucisano G; Genovese S; Pontremoli R; Fioretto P; Giorda C; Pacilli A; Viazzi F; Russo G; Nicolucci A;
    Diabetes Obes Metab; 2017 Nov; 19(11):1570-1578. PubMed ID: 28432733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.
    Pavkov ME; Bennett PH; Knowler WC; Krakoff J; Sievers ML; Nelson RG
    JAMA; 2006 Jul; 296(4):421-6. PubMed ID: 16868300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.